Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Interim Management Statement

9 Dec 2009 07:00

RNS Number : 8057D
S & U PLC
09 December 2009
 



For immediate release 9 December 2009

S&U plc

("S&U" or "the Company")

INTERIM MANAGEMENT STATEMENT

S&U, Britain's foremost niche home credit ("Loansathome4u") and motor finance ("Advantage Finance") provider, today issues an interim management statement for the period from 1st August 2009 to 8th December 2009.

Home Credit

Our well established home credit operations currently account for approximately two thirds of Group profits.  As credit available within the economy has tightened, so the virtues of home credit, which offers flexibility, convenience and excellent service, have appealed to a growing customer base. As a result, trading in the second half thus far has been encouraging, with both revenues and profits in line with our expectations. Debt quality is improving, impairment levels have improved compared to last year, and the profile of our debt has led to increased levels of credit availability for our customers right across the business. As a result, levels of cash generation have remained very good, and we anticipate a successful Christmas period.

Motor Finance

Advantage, our motor finance business, has sensibly adapted to a more challenging non standard market by raising underwriting hurdles and improving the quality of its debt. Its trading performance is in line with budget, reflecting a 5% increase in Live accounts compared to last year. Despite lower levels of customer early redemption, collection rates are driving strong monthly cash generation and impairment levels are stable. 

Funding and Treasury

S&U's balance sheet continues to strengthen and net borrowing has been reduced by £6 million to approximately £27 million as at 8 December 2009 (2008: £33 million) reflecting the Group's strong cash generation. The company has significant headroom within existing facilities for both organic expansion and acquisitions.

 

Commenting on Group trading and outlook, Anthony Coombs, Chairman of S&U plc said:

"The Group is trading in line with market expectations for the year as whole and, as a result of continued prudent management, it is in good shape to exploit the opportunities made available by recent industry consolidation. Whilst we take nothing for granted, we are confident of being able to deliver a sustainable improvement in trading performance both in the current year and early in the new decade."

We will update shareholders on trading in the important Christmas period in a year end trading update at the beginning of February 2010.

For further information, please contact:

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

Charles Stanley Securities

Mark Taylor / Freddy Crossley 020 7149 6000

Smithfield

Katie Hunt / Reg Hoare / Rebecca Whitehead 020 7360 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFGMGZNRRGLZM
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.